Leukapheresis Market Report (2023 to 2031) – Kaneka Corporation, Medica SPA, Miltenyi Biotec, Macopharma, and Terumo BCT, Inc.

Newark, New Castle, USA, May 15, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for leukapheresis in 2022 to be worth US$ 64.7 Million, and it is expected to increase at a revenue CAGR of 8.9% to reach US$ 139.3 Million by 2031.

The global market for leukapheresis was analyzed and is expected to rise significantly in terms of revenue share during the forecast period. White blood cells (leukocytes) important in the body's immunological response are isolated from a blood sample during a medical process called leukapheresis.

Key Takeaways: 

• The rising prevalence of Leukemia is driving the market revenue share.
• Rapid advancement in improving the efficiency and safety of leukapheresis procedures is driving the market demand.
• Extending the use of leukapheresis in treating other illnesses is driving the market revenue share.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/leukapheresis-market/8784

                              Leukapheresis Market Scope

Recent Development in the Global Leukapheresis Market: 

• In June 2021, Adult peripheral blood-derived products, such as vialed PBMCs and whole leukopaks (LeukoPACTM), are now available, according to OrganaBio, LLC. Significant amounts of PBMCs, including T cells, NK cells, B cells, and monocytes, are present in these products. These are essential raw materials for allogeneic cell therapy development and production, as well as immunotherapy research.

Competitive Landscape

A list of the top market players operating in the global market for leukapheresis includes: 

• Kaneka Corporation
• Fresenius SE & Co. KGaA
• Medica SPA
• Asahi Kasei Medical Co. Ltd
• B. Braun Melsungen AG

Market Drivers and Restraints: 

The global leukapheresis market revenue is driven by the rising prevalence of increasing need for leukapheresis products in stem cell transplantation, the growing use of leukapheresis in treating autoimmune diseases, and the rising demand for leukapheresis products in research and clinical applications. Additionally, developing new leukapheresis technologies, such as automated leukapheresis systems and leukapheresis disposables, is likely to contribute potential growth of global market revenue.

However, due to the complexity of leukapheresis procedures, the potential risk of adverse events, the limited availability of donor cells for leukapheresis, and the potential competition from alternative therapies such as pharmacological treatments, the market revenue growth is expected to be restrained. 

Inquiry Before Buying: https://www.growthplusreports.com/inquiry/before-buying/leukapheresis-market/8784

Market Segmentation: 

Segmentation By Product Type

Based on product type, the global leukapheresis market is segmented into leukapheresis devices and leukapheresis disposables. Due to due to more frequent throwaway purchases than device purchases, the leukapheresis disposables segment accounts for the largest market revenue share. 

Segmentation By Application

Based on the application, the global leukapheresis market is segmented into research and therapeutic applications. The research application segment accounts for the largest revenue share due to the rising R&D efforts for the creation of cancer immunotherapies that are effective, together with the use of leukapheresis products in their creation. 

Segmentation By End User 

Based on end-user, the global leukapheresis market is segmented into hospitals & transfusion centers, component providers & blood centers, academic & research institutes, and pharmaceutical & biotechnology companies. Due to the increasing need for blood-related products to treat various clinical illnesses, such as cancer, and expanding public awareness of blood donation through blood donation centers, component providers & blood centers segment with the largest revenue share dominates the global market. 

Regional Growth Dynamics

Based on the region, the global leukapheresis market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to Leukemia's increasing prevalence, the expansion of healthcare infrastructure, expanding R&D efforts, partnerships, mergers, and acquisitions, North America, with the largest revenue share, dominates the global market.

Report Coverage 

Growth Plus Reports studied the global market for leukapheresis in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
   4. Reimbursements
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL LEUKAPHERESIS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
   1. Leukapheresis Devices
      1. Centrifugal Devices
      2. Membrane Separators
   2. Leukapheresis Disposables
6. GLOBAL LEUKAPHERESIS MARKET - ANALYSIS & FORECAST, BY APPLICATION
   1. Research Applications
   2. Therapeutic Applications
7. GLOBAL LEUKAPHERESIS MARKET - ANALYSIS & FORECAST, BY END USER
   1. Hospitals & Transfusion Centers
   2. Component Providers & Blood Centers
   3. Academic & Research Institutes
   4. Pharmaceutical & Biotechnology Companies

LEUKAPHERESIS MARKET TOC      

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8784

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Intestinal Pseudo-Obstruction Treatment Market by Drug Class (Antibiotics, Antidepressants), Route of Administration (Oral, Injectables), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Breast Reconstruction Surgery and Treatment Market by Product (Implant, Tissue Expander), Procedure (Immediate, Delayed), Surgery (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) – Global Outlook & Forecast 2023-2031

Mono Rapid Testing Market by Type (Mono-spot Test, Complete Blood Count Test), End User (Hospital, Speciality Clinics) – Global Outlook & Forecast 2023-2031

Molybdenum-99 Market by Application (Gamma Camera, SPECT), End User (Diagnostic Centers, Hospital) – Global Outlook & Forecast 2021-2031

Untargeted Lipidomics Market by Application (Clinical Diagnostic, Drug Research, and Discovery), Platform (Mass spectrometry, Gas Chromatography), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.